Final CrownBio logo.jpg
New Pancreatic Ductal Adenocarcinoma Research Published in Journal of Visualized Experiments
15 nov. 2018 08h00 HE | Crown Bioscience
Paper describes well-established protocols for PDAC orthotopic tumor homograft model development and immunoprofiling SAN DIEGO, Nov. 15, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience, a global drug...
Final CrownBio logo.jpg
Crown Bioscience Expands Cardiovascular & Metabolic Disease Research Capability
08 nov. 2018 08h00 HE | Crown Bioscience
The Company Offers New Non-GLP Services & Translational Rodent Models at its expanded site in Louisiana SAN DIEGO, Nov. 08, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience, a global drug...
Final CrownBio logo.jpg
CrownBio Completes Validation of Prostate Cancer Patient-Derived Xenograft (PDX) Models
26 sept. 2018 08h00 HE | Crown Bioscience
SAN DIEGO, Sept. 26, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience, a global drug discovery and development services company providing translational platforms to advance oncology, inflammation,...
Final CrownBio logo.jpg
CrownBio Licenses Translational Breast Cancer Models of Resistance and Metastasis
18 sept. 2018 08h00 HE | Crown Bioscience
SAN DIEGO, Sept. 18, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience, a global drug discovery and development services company providing translational platforms to advance oncology, inflammation,...
Final CrownBio logo.jpg
CrownBio erweitert gentechnisch veränderte Modellauswahl durch strategische Partnerschaft mit dem Shanghai Model Organisms Center (SMOC)
14 août 2018 23h50 HE | Crown Bioscience
SAN DIEGO, Aug. 15, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience, ein globales Unternehmen im Bereich der Forschung und Entwicklung von Arzneimitteln, das translationale Plattformen zur...
Final CrownBio logo.jpg
CrownBio étend sa sélection de modèles génétiquement modifiés grâce à une alliance stratégique avec le Shanghai Model Organisms Center (SMOC)
14 août 2018 23h50 HE | Crown Bioscience
SAN DIEGO, 15 août 2018 (GLOBE NEWSWIRE) -- Crown Bioscience, une société mondiale de services de recherche et de développement de médicaments fournissant des plateformes translationnelles en...
Final CrownBio logo.jpg
CrownBio Expands Genetically Engineered Model Selection Via Strategic Alliance with Shanghai Model Organisms Center (SMOC)
14 août 2018 08h00 HE | Crown Bioscience
SAN DIEGO, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Crown Bioscience, a global drug discovery and development services company providing translational platforms to advance oncology, inflammation,...